Re: [HCP-Users] MEG processing pipelines

2018-04-13 Thread Michalareas, Georgios
..@uclouvain.be>>, "hcp-users@humanconnectome.org<mailto:hcp-users@humanconnectome.org>" <hcp-users@humanconnectome.org<mailto:hcp-users@humanconnectome.org>> Subject: Re: [HCP-Users] MEG processing pipelines If you want to match existing 4K data, you shouldn't

Re: [HCP-Users] MEG processing pipelines

2018-04-12 Thread Timothy Coalson
me? Also, should I just use the ft_resampledata Fieldtrip > function in order to go from the 165K or 32K to the 4K dlabel files, or am > I missing something? > > > > Regards, > > > > Benjamin > > > > *De :* Georgios Michalareas <g...@ae.mpg.de>

Re: [HCP-Users] MEG processing pipelines

2018-04-12 Thread Georgios Michalareas
rs@humanconnectome.org *Objet :* Re: [HCP-Users] MEG processing pipelines Hi Benjamin, Sorry for late reply but I was out of office. Regarding single trial source analysis I have put together some code that shows you how to project all motor trials for LH into source space in a matrix with

Re: [HCP-Users] MEG processing pipelines

2018-04-10 Thread Benjamin Chiêm
, Benjamin De : Georgios Michalareas <g...@ae.mpg.de> Envoyé : lundi 26 mars 2018 19:20 À : Benjamin Chiêm <benjamin.ch...@uclouvain.be>; hcp-users@humanconnectome.org Objet : Re: [HCP-Users] MEG processing pipelines Hi Benjamin, Sorry for late reply but I was out of office. Rega

Re: [HCP-Users] MEG processing pipelines

2018-03-26 Thread Georgios Michalareas
Hi Benjamin, Sorry for late reply but I was out of office. Regarding single trial source analysis I have put together some code that shows you how to project all motor trials for LH into source space in a matrix with dimensions: Nsources * Ntimespoints * Ntrials beware this matrix for the

[HCP-Users] MEG processing pipelines

2018-03-16 Thread Benjamin Chiêm
Dear HCP experts, In the context of my PhD thesis (using HCP data), I had some questions about MEG processing pipelines. In my research, I somehow need the MEG data during motor task, in the source space (i.e. after beamforming), for each trial and each individual separately. It seems that the